Physician profile
Young H Oh
NPI 1255308672
$4,295.72
in general payments reported to CMS, 2019-2025
27 companies · $1,922 in 2025
The $1,922 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $265 · 2021: $289 · 2022: $279 · 2023: $229 · 2024: $480 · 2025: $1,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419 · Travel and Lodging: $1,136 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.88 |
| Travel and Lodging | $1,135.66 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,684.55 | 2025 | Oxford |
| Janssen Pharmaceuticals, INC | $399.32 | 2019-2020 | |
| Stryker Corporation | $342.27 | 2020-2024 | Mako, T2 |
| Endo USA, INC. | $201.99 | 2024-2025 | Xiaflex |
| Davol INC. | $161.34 | 2024 | |
| Allergan, INC. | $144.39 | 2019 | |
| Pfizer INC. | $128.46 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2022 | |
| Sanara Medtech INC. | $120.06 | 2022 | |
| Amgen INC. | $113.88 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $109.62 | 2023-2025 | Exparel, Zilretta, Iovera |
| Vifor Pharma, INC. | $99.06 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $95.79 | 2019 | |
| Depuy Synthes Sales INC. | $82.15 | 2023 | Na |
| Wright Medical Technology, INC. | $76.82 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $73.27 | 2019 | |
| Bioventus LLC | $64.82 | 2021-2025 | Durolane |
| Medtronic, INC. | $61.13 | 2025 | Venaseal |
| Medical Device Business Services, INC. | $41.60 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.87 | 2021 | |
| Avanos Medical | $22.13 | 2019 | |
| Abbvie INC. | $19.57 | 2019 | |
| Smith+Nephew, INC. | $17.84 | 2020 | |
| Dynasplint Systems INC. | $17.83 | 2023 | Dynasplint |
| Heraeus Medical, LLC. | $16.38 | 2021 | |
| Endo Pharmaceuticals INC. | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.